- Home
- VRDN vs AHCO Comparison
VRDN vs AHCO Comparison
Compare VRDN & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- AHCO
- Stock Information
- Founded
- VRDN 2006
- AHCO N/A
- Country
- VRDN United States
- AHCO United States
- Employees
- VRDN N/A
- AHCO N/A
- Industry
- VRDN Medical Specialities
- AHCO Medical/Nursing Services
- Sector
- VRDN Health Care
- AHCO Health Care
- Exchange
- VRDN Nasdaq
- AHCO Nasdaq
- Market Cap
- VRDN 1.6B
- AHCO 1.3B
- IPO Year
- VRDN N/A
- AHCO N/A
- Fundamental
- Price
- VRDN $16.27
- AHCO $8.45
- Analyst Decision
- VRDN Buy
- AHCO Strong Buy
- Analyst Count
- VRDN 12
- AHCO 5
- Target Price
- VRDN $36.44
- AHCO $12.20
- AVG Volume (30 Days)
- VRDN 979.5K
- AHCO 1.0M
- Earning Date
- VRDN 03-04-2025
- AHCO 02-25-2025
- Dividend Yield
- VRDN N/A
- AHCO N/A
- EPS Growth
- VRDN N/A
- AHCO N/A
- EPS
- VRDN N/A
- AHCO N/A
- Revenue
- VRDN $302,000.00
- AHCO $3,262,564,000.00
- Revenue This Year
- VRDN $3.30
- AHCO $3.06
- Revenue Next Year
- VRDN N/A
- AHCO $2.97
- P/E Ratio
- VRDN N/A
- AHCO N/A
- Revenue Growth
- VRDN N/A
- AHCO 4.49
- 52 Week Low
- VRDN $11.40
- AHCO $7.25
- 52 Week High
- VRDN $27.20
- AHCO $11.90
- Technical
- Relative Strength Index (RSI)
- VRDN 36.43
- AHCO 29.42
- Support Level
- VRDN $15.62
- AHCO $8.58
- Resistance Level
- VRDN $18.15
- AHCO $9.10
- Average True Range (ATR)
- VRDN 0.91
- AHCO 0.40
- MACD
- VRDN -0.20
- AHCO -0.13
- Stochastic Oscillator
- VRDN 14.48
- AHCO 4.12
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.